 | • レポートコード：QY2108PAL8925 • 出版社/出版日：QYResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、150ページ • 納品方法：Eメール（納期：1日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の当調査資料ではグローバルにおける放射性医薬品の市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、放射性医薬品の種類別市場規模（アクチニウム-225、ルテチウム-177、ラジウム-223、ホルミウム-166、その他）、用途別市場規模（腫瘍、心臓病、その他）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界の放射性医薬品市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界における放射性医薬品の種類別市場規模（2016年-2027年）：アクチニウム-225、ルテチウム-177、ラジウム-223、ホルミウム-166、その他 ・世界における放射性医薬品の用途別市場規模（2016年-2027年）：腫瘍、心臓病、その他 ・放射性医薬品の中国市場分析 - 放射性医薬品の中国市場規模（2016年-2027年） - 中国における放射性医薬品の主要プレイヤー別市場シェア - 中国における放射性医薬品の種類別市場規模：アクチニウム-225、ルテチウム-177、ラジウム-223、ホルミウム-166、その他 - 中国における放射性医薬品の用途別市場規模：腫瘍、心臓病、その他 ・放射性医薬品の北米市場（2016年-2027年） ・放射性医薬品のヨーロッパ市場（2016年-2027年） ・放射性医薬品のアジア太平洋市場（2016年-2027年） ・放射性医薬品の中南米市場（2016年-2027年） ・放射性医薬品の中東・アフリカ市場（2016年-2027年） ・主要プレイヤーの情報：Bracco Imaging、Bayer、Mallinckrodt、Nordion、Triad Isotopes、Lantheus、IBA Group、GE Healthcare、China Isotope & Radiation、Jubilant Pharma、Eli Lilly、Advanced Accelerator Applications、SIEMENS、Dongcheng、Navidea ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・... |
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
The global Radiopharmaceutical top three manufacturers include the Bracco Imaging, Bayer and Mallinckrodt, with about 47% market shares. North America and Europe is the main consumption places, with a consumption market share nearly 45% and 27%.
Market Analysis and Insights: Global and China Radiopharmaceutical Market
This report focuses on global and China Radiopharmaceutical market.
In 2020, the global Radiopharmaceutical market size was US$ 6326 million and it is expected to reach US$ 11280 million by the end of 2027, with a CAGR of 8.6% during 2021-2027. In China the Radiopharmaceutical market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Radiopharmaceutical Scope and Market Size
Radiopharmaceutical market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Radiopharmaceutical market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Radiopharmaceutical market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
Actinium-225
Lutetium-177
Radium-223
Holmium-166
Other
Segment by Application
Oncology
Cardiology
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea
1 Study Coverage
1.1 Radiopharmaceutical Product Introduction
1.2 Market by Type
1.2.1 Global Radiopharmaceutical Market Size Growth Rate by Type
1.2.2 Actinium-225
1.2.3 Lutetium-177
1.2.4 Radium-223
1.2.5 Holmium-166
1.2.6 Other
1.3 Market by Application
1.3.1 Global Radiopharmaceutical Market Size Growth Rate by Application
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Radiopharmaceutical Market Size, Estimates and Forecasts
2.1.1 Global Radiopharmaceutical Revenue 2016-2027
2.1.2 Global Radiopharmaceutical Sales 2016-2027
2.2 Global Radiopharmaceutical, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Radiopharmaceutical Historical Market Size by Region (2016-2021)
2.3.1 Global Radiopharmaceutical Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Radiopharmaceutical Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Radiopharmaceutical Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Radiopharmaceutical Sales Forecast by Region (2022-2027)
2.4.2 Global Radiopharmaceutical Revenue Forecast by Region (2022-2027)
3 Global Radiopharmaceutical Competitor Landscape by Players
3.1 Global Top Radiopharmaceutical Manufacturers by Sales
3.1.1 Global Radiopharmaceutical Sales by Manufacturer (2016-2021)
3.1.2 Global Radiopharmaceutical Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Radiopharmaceutical Manufacturers by Revenue
3.2.1 Key Radiopharmaceutical Manufacturers Covered: Ranking by Revenue
3.2.2 Global Radiopharmaceutical Revenue by Manufacturers (2016-2021)
3.2.3 Global Radiopharmaceutical Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Radiopharmaceutical Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Radiopharmaceutical Revenue in 2020
3.2.6 Global Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Radiopharmaceutical Price by Manufacturers
3.4 Global Radiopharmaceutical Manufacturing Base Distribution, Product Types
3.4.1 Radiopharmaceutical Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Radiopharmaceutical Product Type
3.4.3 Date of International Manufacturers Enter into Radiopharmaceutical Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Radiopharmaceutical Market Size by Type (2016-2021)
4.1.1 Global Radiopharmaceutical Sales by Type (2016-2021)
4.1.2 Global Radiopharmaceutical Revenue by Type (2016-2021)
4.1.3 Radiopharmaceutical Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Radiopharmaceutical Market Size Forecast by Type (2022-2027)
4.2.1 Global Radiopharmaceutical Sales Forecast by Type (2022-2027)
4.2.2 Global Radiopharmaceutical Revenue Forecast by Type (2022-2027)
4.2.3 Radiopharmaceutical Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Radiopharmaceutical Market Size by Application (2016-2021)
5.1.1 Global Radiopharmaceutical Sales by Application (2016-2021)
5.1.2 Global Radiopharmaceutical Revenue by Application (2016-2021)
5.1.3 Radiopharmaceutical Price by Application (2016-2021)
5.2 Radiopharmaceutical Market Size Forecast by Application (2022-2027)
5.2.1 Global Radiopharmaceutical Sales Forecast by Application (2022-2027)
5.2.2 Global Radiopharmaceutical Revenue Forecast by Application (2022-2027)
5.2.3 Global Radiopharmaceutical Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Radiopharmaceutical Market Size YoY Growth 2016-2027
6.1.1 China Radiopharmaceutical Sales YoY Growth 2016-2027
6.1.2 China Radiopharmaceutical Revenue YoY Growth 2016-2027
6.1.3 China Radiopharmaceutical Market Share in Global Market 2016-2027
6.2 China Radiopharmaceutical Market Size by Players (International and Local Players)
6.2.1 China Top Radiopharmaceutical Players by Sales (2016-2021)
6.2.2 China Top Radiopharmaceutical Players by Revenue (2016-2021)
6.3 China Radiopharmaceutical Historic Market Review by Type (2016-2021)
6.3.1 China Radiopharmaceutical Sales Market Share by Type (2016-2021)
6.3.2 China Radiopharmaceutical Revenue Market Share by Type (2016-2021)
6.3.3 China Radiopharmaceutical Price by Type (2016-2021)
6.4 China Radiopharmaceutical Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Radiopharmaceutical Sales Forecast by Type (2022-2027)
6.4.2 China Radiopharmaceutical Revenue Forecast by Type (2022-2027)
6.4.3 China Radiopharmaceutical Price Forecast by Type (2022-2027)
6.5 China Radiopharmaceutical Historic Market Review by Application (2016-2021)
6.5.1 China Radiopharmaceutical Sales Market Share by Application (2016-2021)
6.5.2 China Radiopharmaceutical Revenue Market Share by Application (2016-2021)
6.5.3 China Radiopharmaceutical Price by Application (2016-2021)
6.6 China Radiopharmaceutical Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Radiopharmaceutical Sales Forecast by Application (2022-2027)
6.6.2 China Radiopharmaceutical Revenue Forecast by Application (2022-2027)
6.6.3 China Radiopharmaceutical Price Forecast by Application (2022-2027)
7 North America
7.1 North America Radiopharmaceutical Market Size YoY Growth 2016-2027
7.2 North America Radiopharmaceutical Market Facts & Figures by Country
7.2.1 North America Radiopharmaceutical Sales by Country (2016-2021)
7.2.2 North America Radiopharmaceutical Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Radiopharmaceutical Market Size YoY Growth 2016-2027
8.2 Asia Pacific Radiopharmaceutical Market Facts & Figures by Region
8.2.1 Asia Pacific Radiopharmaceutical Sales by Region (2016-2021)
8.2.2 Asia Pacific Radiopharmaceutical Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Radiopharmaceutical Market Size YoY Growth 2016-2027
9.2 Europe Radiopharmaceutical Market Facts & Figures by Country
9.2.1 Europe Radiopharmaceutical Sales by Country (2016-2021)
9.2.2 Europe Radiopharmaceutical Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Radiopharmaceutical Market Size YoY Growth 2016-2027
10.2 Latin America Radiopharmaceutical Market Facts & Figures by Country
10.2.1 Latin America Radiopharmaceutical Sales by Country (2016-2021)
10.2.2 Latin America Radiopharmaceutical Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Radiopharmaceutical Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Radiopharmaceutical Market Facts & Figures by Country
11.2.1 Middle East and Africa Radiopharmaceutical Sales by Country (2016-2021)
11.2.2 Middle East and Africa Radiopharmaceutical Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Bracco Imaging
12.1.1 Bracco Imaging Corporation Information
12.1.2 Bracco Imaging Description and Business Overview
12.1.3 Bracco Imaging Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Bracco Imaging Radiopharmaceutical Products Offered
12.1.5 Bracco Imaging Recent Development
12.2 Bayer
12.2.1 Bayer Corporation Information
12.2.2 Bayer Description and Business Overview
12.2.3 Bayer Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Bayer Radiopharmaceutical Products Offered
12.2.5 Bayer Recent Development
12.3 Mallinckrodt
12.3.1 Mallinckrodt Corporation Information
12.3.2 Mallinckrodt Description and Business Overview
12.3.3 Mallinckrodt Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Mallinckrodt Radiopharmaceutical Products Offered
12.3.5 Mallinckrodt Recent Development
12.4 Nordion
12.4.1 Nordion Corporation Information
12.4.2 Nordion Description and Business Overview
12.4.3 Nordion Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Nordion Radiopharmaceutical Products Offered
12.4.5 Nordion Recent Development
12.5 Triad Isotopes
12.5.1 Triad Isotopes Corporation Information
12.5.2 Triad Isotopes Description and Business Overview
12.5.3 Triad Isotopes Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Triad Isotopes Radiopharmaceutical Products Offered
12.5.5 Triad Isotopes Recent Development
12.6 Lantheus
12.6.1 Lantheus Corporation Information
12.6.2 Lantheus Description and Business Overview
12.6.3 Lantheus Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Lantheus Radiopharmaceutical Products Offered
12.6.5 Lantheus Recent Development
12.7 IBA Group
12.7.1 IBA Group Corporation Information
12.7.2 IBA Group Description and Business Overview
12.7.3 IBA Group Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
12.7.4 IBA Group Radiopharmaceutical Products Offered
12.7.5 IBA Group Recent Development
12.8 GE Healthcare
12.8.1 GE Healthcare Corporation Information
12.8.2 GE Healthcare Description and Business Overview
12.8.3 GE Healthcare Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
12.8.4 GE Healthcare Radiopharmaceutical Products Offered
12.8.5 GE Healthcare Recent Development
12.9 China Isotope & Radiation
12.9.1 China Isotope & Radiation Corporation Information
12.9.2 China Isotope & Radiation Description and Business Overview
12.9.3 China Isotope & Radiation Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
12.9.4 China Isotope & Radiation Radiopharmaceutical Products Offered
12.9.5 China Isotope & Radiation Recent Development
12.10 Jubilant Pharma
12.10.1 Jubilant Pharma Corporation Information
12.10.2 Jubilant Pharma Description and Business Overview
12.10.3 Jubilant Pharma Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Jubilant Pharma Radiopharmaceutical Products Offered
12.10.5 Jubilant Pharma Recent Development
12.11 Bracco Imaging
12.11.1 Bracco Imaging Corporation Information
12.11.2 Bracco Imaging Description and Business Overview
12.11.3 Bracco Imaging Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Bracco Imaging Radiopharmaceutical Products Offered
12.11.5 Bracco Imaging Recent Development
12.12 Advanced Accelerator Applications
12.12.1 Advanced Accelerator Applications Corporation Information
12.12.2 Advanced Accelerator Applications Description and Business Overview
12.12.3 Advanced Accelerator Applications Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Advanced Accelerator Applications Products Offered
12.12.5 Advanced Accelerator Applications Recent Development
12.13 SIEMENS
12.13.1 SIEMENS Corporation Information
12.13.2 SIEMENS Description and Business Overview
12.13.3 SIEMENS Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
12.13.4 SIEMENS Products Offered
12.13.5 SIEMENS Recent Development
12.14 Dongcheng
12.14.1 Dongcheng Corporation Information
12.14.2 Dongcheng Description and Business Overview
12.14.3 Dongcheng Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Dongcheng Products Offered
12.14.5 Dongcheng Recent Development
12.15 Navidea
12.15.1 Navidea Corporation Information
12.15.2 Navidea Description and Business Overview
12.15.3 Navidea Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Navidea Products Offered
12.15.5 Navidea Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Radiopharmaceutical Industry Trends
13.2 Radiopharmaceutical Market Drivers
13.3 Radiopharmaceutical Market Challenges
13.4 Radiopharmaceutical Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Radiopharmaceutical Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Radiopharmaceutical Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Actinium-225
Table 3. Major Manufacturers of Lutetium-177
Table 4. Major Manufacturers of Radium-223
Table 5. Major Manufacturers of Holmium-166
Table 6. Major Manufacturers of Other
Table 7. Global Radiopharmaceutical Market Size Growth Rate by Application (2021-2027) & (M Doses)
Table 8. Global Radiopharmaceutical Market Size by Region (M Doses) & (US$ Million), 2016 VS 2021 VS 2027
Table 9. Global Radiopharmaceutical Sales by Regions (2016-2021) & (M Doses)
Table 10. Global Radiopharmaceutical Sales Market Share by Regions (2016-2021)
Table 11. Global Radiopharmaceutical Revenue by Regions (2016-2021) & (US$ Million)
Table 12. Global Radiopharmaceutical Sales Forecast by Region (2022-2027) & (M Doses)
Table 13. Global Radiopharmaceutical Sales Market Share Forecast by Region (2022-2027)
Table 14. Global Radiopharmaceutical Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 15. Global Radiopharmaceutical Revenue Market Share Forecast by Region (2022-2027)
Table 16. Global Radiopharmaceutical Sales by Manufacturers (2016-2021) (M Doses)
Table 17. Global Radiopharmaceutical Sales Share by Manufacturers (2016-2021)
Table 18. Ranking of Global Top Radiopharmaceutical Manufacturers by Revenue (US$ Million) in 2020
Table 19. Radiopharmaceutical Revenue by Manufacturers (2016-2021) (US$ Million)
Table 20. Radiopharmaceutical Revenue Share by Manufacturers (2016-2021)
Table 21. Global Radiopharmaceutical Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 22. Global Radiopharmaceutical by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Radiopharmaceutical as of 2020)
Table 23. Key Manufacturers Radiopharmaceutical Price (2016-2021) (USD/Dose)
Table 24. Radiopharmaceutical Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Radiopharmaceutical Product Type
Table 26. Date of International Manufacturers Enter into Radiopharmaceutical Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Radiopharmaceutical Sales by Type (2016-2021) (M Doses)
Table 29. Global Radiopharmaceutical Sales Share by Type (2016-2021)
Table 30. Global Radiopharmaceutical Revenue by Type (2016-2021) (US$ Million)
Table 31. Global Radiopharmaceutical Revenue Share by Type (2016-2021)
Table 32. Radiopharmaceutical Average Selling Price (ASP) by Type (2016-2021) & (USD/Dose)
Table 33. Global Radiopharmaceutical Sales Forecast by Type (2022-2027) & (M Doses)
Table 34. Global Radiopharmaceutical Sales Market Share Forecast by Type (2022-2027)
Table 35. Global Radiopharmaceutical Revenue Forecast V (2022-2027) & (US$ Million)
Table 36. Global Radiopharmaceutical Revenue Market Share Forecast by Type (2022-2027)
Table 37. Global Radiopharmaceutical Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Dose)
Table 38. Global Radiopharmaceutical Sales by Application (2016-2021) (M Doses)
Table 39. Global Radiopharmaceutical Sales Share by Application (2016-2021)
Table 40. Global Radiopharmaceutical Revenue by Application (2016-2021) (US$ Million)
Table 41. Global Radiopharmaceutical Revenue Share by Application (2016-2021)
Table 42. Radiopharmaceutical Average Selling Price (ASP) by Application (2016-2021) & (USD/Dose)
Table 43. Global Radiopharmaceutical Sales Forecast by Application (2022-2027) & (M Doses)
Table 44. Global Radiopharmaceutical Sales Market Share Forecast by Application (2022-2027)
Table 45. Global Radiopharmaceutical Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 46. Global Radiopharmaceutical Revenue Market Share Forecast by Application (2022-2027)
Table 47. Global Radiopharmaceutical Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Dose)
Table 48. China Radiopharmaceutical Sales (M Doses) of Key Companies (2016-2021)
Table 49. China Radiopharmaceutical Sales Share by Company (2016-2021)
Table 50. China Radiopharmaceutical Revenue (US$ Million) by Company (2016-2021)
Table 51. China Radiopharmaceutical Revenue Share by Company (2016-2021)
Table 52. China Radiopharmaceutical Sales (M Doses) by Type (2016-2021)
Table 53. China Radiopharmaceutical Sales Share by Type (2016-2021)
Table 54. China Radiopharmaceutical Revenue (US$ Million) Market Share by Type (2016-2021)
Table 55. China Radiopharmaceutical Price (USD/Dose) by Type (2016-2021)
Table 56. China Radiopharmaceutical Sales (M Doses) by Type (2022-2027)
Table 57. China Radiopharmaceutical Sales Share by Type (2022-2027)
Table 58. China Radiopharmaceutical Revenue (US$ Million) Market Share by Type (2022-2027)
Table 59. China Radiopharmaceutical Revenue Share by Type (2022-2027)
Table 60. China Radiopharmaceutical Price (USD/Dose) by Type (2022-2027)
Table 61. China Radiopharmaceutical Sales (M Doses) by Application (2016-2021)
Table 62. China Radiopharmaceutical Sales Share by Application (2016-2021)
Table 63. China Radiopharmaceutical Revenue (US$ Million) Market Share by Application (2016-2021)
Table 64. China Radiopharmaceutical Price (USD/Dose) by Application (2016-2021)
Table 65. China Radiopharmaceutical Sales (M Doses) by Application (2022-2027)
Table 66. China Radiopharmaceutical Sales Share by Application (2022-2027)
Table 67. China Radiopharmaceutical Revenue (US$ Million) Market Share by Application (2022-2027)
Table 68. China Radiopharmaceutical Revenue Share by Application (2022-2027)
Table 69. China Radiopharmaceutical Price (USD/Dose) by Application (2022-2027)
Table 70. North America Radiopharmaceutical Sales by Country (2016-2021) & (M Doses)
Table 71. North America Radiopharmaceutical Sales Market Share by Country (2016-2021)
Table 72. North America Radiopharmaceutical Revenue by Country (2016-2021) & (US$ Million)
Table 73. North America Radiopharmaceutical Revenue Market Share by Country (2016-2021)
Table 74. Asia Pacific Radiopharmaceutical Sales by Region (2016-2021) & (M Doses)
Table 75. Asia Pacific Radiopharmaceutical Sales Market Share by Region (2016-2021)
Table 76. Asia Pacific Radiopharmaceutical Revenue by Region (2016-2021) & (US$ Million)
Table 77. Asia Pacific Radiopharmaceutical Revenue Market Share by Region (2016-2021)
Table 78. Europe Radiopharmaceutical Sales by Country (2016-2021) & (M Doses)
Table 79. Europe Radiopharmaceutical Sales Market Share by Country (2016-2021)
Table 80. Europe Radiopharmaceutical Revenue by Country (2016-2021) & (US$ Million)
Table 81. Europe Radiopharmaceutical Revenue Market Share by Country (2016-2021)
Table 82. Latin America Radiopharmaceutical Sales by Country (2016-2021) & (M Doses)
Table 83. Latin America Radiopharmaceutical Sales Market Share by Country (2016-2021)
Table 84. Latin Americaa Radiopharmaceutical Revenue by Country (2016-2021) & (US$ Million)
Table 85. Latin America Radiopharmaceutical Revenue Market Share by Country (2016-2021)
Table 86. Middle East and Africa Radiopharmaceutical Sales by Country (2016-2021) & (M Doses)
Table 87. Middle East and Africa Radiopharmaceutical Sales Market Share by Country (2016-2021)
Table 88. Middle East and Africa Radiopharmaceutical Revenue by Country (2016-2021) & (US$ Million)
Table 89. Middle East and Africa Radiopharmaceutical Revenue Market Share by Country (2016-2021)
Table 90. Bracco Imaging Corporation Information
Table 91. Bracco Imaging Description and Business Overview
Table 92. Bracco Imaging Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 93. Bracco Imaging Radiopharmaceutical Product
Table 94. Bracco Imaging Recent Development
Table 95. Bayer Corporation Information
Table 96. Bayer Description and Business Overview
Table 97. Bayer Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 98. Bayer Product
Table 99. Bayer Recent Development
Table 100. Mallinckrodt Corporation Information
Table 101. Mallinckrodt Description and Business Overview
Table 102. Mallinckrodt Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 103. Mallinckrodt Product
Table 104. Mallinckrodt Recent Development
Table 105. Nordion Corporation Information
Table 106. Nordion Description and Business Overview
Table 107. Nordion Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 108. Nordion Product
Table 109. Nordion Recent Development
Table 110. Triad Isotopes Corporation Information
Table 111. Triad Isotopes Description and Business Overview
Table 112. Triad Isotopes Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 113. Triad Isotopes Product
Table 114. Triad Isotopes Recent Development
Table 115. Lantheus Corporation Information
Table 116. Lantheus Description and Business Overview
Table 117. Lantheus Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 118. Lantheus Product
Table 119. Lantheus Recent Development
Table 120. IBA Group Corporation Information
Table 121. IBA Group Description and Business Overview
Table 122. IBA Group Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 123. IBA Group Product
Table 124. IBA Group Recent Development
Table 125. GE Healthcare Corporation Information
Table 126. GE Healthcare Description and Business Overview
Table 127. GE Healthcare Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 128. GE Healthcare Product
Table 129. GE Healthcare Recent Development
Table 130. China Isotope & Radiation Corporation Information
Table 131. China Isotope & Radiation Description and Business Overview
Table 132. China Isotope & Radiation Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 133. China Isotope & Radiation Product
Table 134. China Isotope & Radiation Recent Development
Table 135. Jubilant Pharma Corporation Information
Table 136. Jubilant Pharma Description and Business Overview
Table 137. Jubilant Pharma Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 138. Jubilant Pharma Product
Table 139. Jubilant Pharma Recent Development
Table 140. Eli Lilly Corporation Information
Table 141. Eli Lilly Description and Business Overview
Table 142. Eli Lilly Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 143. Eli Lilly Product
Table 144. Eli Lilly Recent Development
Table 145. Advanced Accelerator Applications Corporation Information
Table 146. Advanced Accelerator Applications Description and Business Overview
Table 147. Advanced Accelerator Applications Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 148. Advanced Accelerator Applications Product
Table 149. Advanced Accelerator Applications Recent Development
Table 150. SIEMENS Corporation Information
Table 151. SIEMENS Description and Business Overview
Table 152. SIEMENS Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 153. SIEMENS Product
Table 154. SIEMENS Recent Development
Table 155. Dongcheng Corporation Information
Table 156. Dongcheng Description and Business Overview
Table 157. Dongcheng Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 158. Dongcheng Product
Table 159. Dongcheng Recent Development
Table 160. Navidea Corporation Information
Table 161. Navidea Description and Business Overview
Table 162. Navidea Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 163. Navidea Product
Table 164. Navidea Recent Development
Table 165. Radiopharmaceutical Market Trends
Table 166. Radiopharmaceutical Market Drivers
Table 167. Radiopharmaceutical Market Challenges
Table 168. Radiopharmaceutical Market Restraints
Table 169. Radiopharmaceutical Customers List
Table 170. Radiopharmaceutical Distributors List
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Radiopharmaceutical Product Picture
Figure 2. Global Radiopharmaceutical Sales Market Share by Type in 2020 & 2027
Figure 3. Actinium-225 Product Picture
Figure 4. Lutetium-177 Product Picture
Figure 5. Radium-223 Product Picture
Figure 6. Holmium-166 Product Picture
Figure 7. Other Product Picture
Figure 8. Global Radiopharmaceutical Sales Market Share by Application in 2020 & 2027
Figure 9. Oncology
Figure 10. Cardiology
Figure 11. Other
Figure 12. Radiopharmaceutical Report Years Considered
Figure 13. Global Radiopharmaceutical Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Radiopharmaceutical Market Size 2016-2027 (US$ Million)
Figure 15. Global Radiopharmaceutical Sales 2016-2027 (M Doses)
Figure 16. Global Radiopharmaceutical Market Size Market Share by Region: 2021 Versus 2027
Figure 17. Global Radiopharmaceutical Sales Market Share by Region (2016-2021)
Figure 18. Global Radiopharmaceutical Sales Market Share by Region in 2020
Figure 19. Global Radiopharmaceutical Revenue Market Share by Region (2016-2021)
Figure 20. Global Radiopharmaceutical Revenue Market Share by Region in 2020
Figure 21. Global Radiopharmaceutical Sales Share by Manufacturer in 2020
Figure 22. The Top 10 and 5 Players Market Share by Radiopharmaceutical Revenue in 2020
Figure 23. Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 24. Global Radiopharmaceutical Sales Market Share by Type (2016-2021)
Figure 25. Global Radiopharmaceutical Sales Market Share by Type in 2020
Figure 26. Global Radiopharmaceutical Revenue Market Share by Type (2016-2021)
Figure 27. Global Radiopharmaceutical Revenue Market Share by Type in 2020
Figure 28. Global Radiopharmaceutical Sales Market Share by Application (2016-2021)
Figure 29. Global Radiopharmaceutical Sales Market Share by Application in 2020
Figure 30. Global Radiopharmaceutical Revenue Market Share by Application (2016-2021)
Figure 31. Global Radiopharmaceutical Revenue Market Share by Application in 2020
Figure 32. China Radiopharmaceutical Sales Growth Rate 2016-2027 (M Doses)
Figure 33. China Radiopharmaceutical Revenue Growth Rate 2016-2027 (US$ Million)
Figure 34. China Radiopharmaceutical Market Share in Global Market 2016-2027
Figure 35. China 5 and 10 Largest Radiopharmaceutical Players Market Share by Revenue in Radiopharmaceutical in 2020
Figure 36. China Radiopharmaceutical Revenue Share by Type (2016-2021)
Figure 37. China Radiopharmaceutical Revenue Growth Rate by Type in 2016 & 2020
Figure 38. China Radiopharmaceutical Revenue Share by Application (2016-2021)
Figure 39. China Radiopharmaceutical Revenue Growth Rate by Application in 2016 & 2020
Figure 40. North America Radiopharmaceutical Sales Growth Rate 2016-2021 (M Doses)
Figure 41. North America Radiopharmaceutical Revenue Growth Rate 2016-2021 (US$ Million)
Figure 42. North America Radiopharmaceutical Sales Market Share by Country in 2020
Figure 43. North America Radiopharmaceutical Revenue Market Share by Country in 2020
Figure 44. U.S. Radiopharmaceutical Sales Growth Rate (2016-2021) (M Doses)
Figure 45. U.S. Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Canada Radiopharmaceutical Sales Growth Rate (2016-2021) (M Doses)
Figure 47. Canada Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Europe Radiopharmaceutical Sales Growth Rate 2016-2021 (M Doses)
Figure 49. Europe Radiopharmaceutical Revenue Growth Rate 2016-2021 (US$ Million)
Figure 50. Europe Radiopharmaceutical Sales Market Share by Country in 2020
Figure 51. Europe Radiopharmaceutical Revenue Market Share by Country in 2020
Figure 52. Germany Radiopharmaceutical Sales Growth Rate (2016-2021) (M Doses)
Figure 53. Germany Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. France Radiopharmaceutical Sales Growth Rate (2016-2021) (M Doses)
Figure 55. France Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. U.K. Radiopharmaceutical Sales Growth Rate (2016-2021) (M Doses)
Figure 57. U.K. Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Italy Radiopharmaceutical Sales Growth Rate (2016-2021) (M Doses)
Figure 59. Italy Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Russia Radiopharmaceutical Sales Growth Rate (2016-2021) (M Doses)
Figure 61. Russia Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 62. Asia Pacific Radiopharmaceutical Sales Growth Rate 2016-2021 (M Doses)
Figure 63. Asia Pacific Radiopharmaceutical Revenue Growth Rate 2016-2021 (US$ Million)
Figure 64. Asia Pacific Radiopharmaceutical Sales Market Share by Region in 2020
Figure 65. Asia Pacific Radiopharmaceutical Revenue Market Share by Region in 2020
Figure 66. China Radiopharmaceutical Sales Growth Rate (2016-2021) (M Doses)
Figure 67. China Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. Japan Radiopharmaceutical Sales Growth Rate (2016-2021) (M Doses)
Figure 69. Japan Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. South Korea Radiopharmaceutical Sales Growth Rate (2016-2021) (M Doses)
Figure 71. South Korea Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. India Radiopharmaceutical Sales Growth Rate (2016-2021) (M Doses)
Figure 73. India Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Australia Radiopharmaceutical Sales Growth Rate (2016-2021) (M Doses)
Figure 75. Australia Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Taiwan Radiopharmaceutical Sales Growth Rate (2016-2021) (M Doses)
Figure 77. Taiwan Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Indonesia Radiopharmaceutical Sales Growth Rate (2016-2021) (M Doses)
Figure 79. Indonesia Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Thailand Radiopharmaceutical Sales Growth Rate (2016-2021) (M Doses)
Figure 81. Thailand Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Malaysia Radiopharmaceutical Sales Growth Rate (2016-2021) (M Doses)
Figure 83. Malaysia Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Philippines Radiopharmaceutical Sales Growth Rate (2016-2021) (M Doses)
Figure 85. Philippines Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 86. Vietnam Radiopharmaceutical Sales Growth Rate (2016-2021) (M Doses)
Figure 87. Vietnam Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 88. Latin America Radiopharmaceutical Sales Growth Rate 2016-2021 (M Doses)
Figure 89. Latin America Radiopharmaceutical Revenue Growth Rate 2016-2021 (US$ Million)
Figure 90. Latin America Radiopharmaceutical Sales Market Share by Country in 2020
Figure 91. Latin America Radiopharmaceutical Revenue Market Share by Country in 2020
Figure 92. Mexico Radiopharmaceutical Sales Growth Rate (2016-2021) (M Doses)
Figure 93. Mexico Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 94. Brazil Radiopharmaceutical Sales Growth Rate (2016-2021) (M Doses)
Figure 95. Brazil Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 96. Argentina Radiopharmaceutical Sales Growth Rate (2016-2021) (M Doses)
Figure 97. Argentina Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 98. Middle East and Africa Radiopharmaceutical Sales Growth Rate 2016-2021 (M Doses)
Figure 99. Middle East and Africa Radiopharmaceutical Revenue Growth Rate 2016-2021 (US$ Million)
Figure 100. Middle East and Africa Radiopharmaceutical Sales Market Share by Country in 2020
Figure 101. Middle East and Africa Radiopharmaceutical Revenue Market Share by Country in 2020
Figure 102. Turkey Radiopharmaceutical Sales Growth Rate (2016-2021) (M Doses)
Figure 103. Turkey Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 104. Saudi Arabia Radiopharmaceutical Sales Growth Rate (2016-2021) (M Doses)
Figure 105. Saudi Arabia Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 106. U.A.E Radiopharmaceutical Sales Growth Rate (2016-2021) (M Doses)
Figure 107. U.A.E Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 108. Radiopharmaceutical Value Chain
Figure 109. Channels of Distribution
Figure 110. Distributors Profiles
Figure 111. Bottom-up and Top-down Approaches for This Report
Figure 112. Data Triangulation
Figure 113. Key Executives Interviewed